"POEMS Syndrome/drug therapy"[MAJR] - Search Results

Year	Number of Results
1992	2
1995	1
1996	1
1997	1
1998	2
1999	1
2001	1
2003	1
2004	2
2005	2
2006	3
2007	4
2008	2
2009	5
2010	9
2011	6
2012	11
2013	6
2014	3
2015	6
2016	2
2017	3
2018	7
2019	5
2020	3
2021	7
2022	7
2023	6
2024	2

1

Update on the Diagnosis and Treatment of POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes) Syndrome: A Review.

Khouri J, Nakashima M, Wong S. Khouri J, et al. JAMA Oncol. 2021 Sep 1;7(9):1383-1391. doi: 10.1001/jamaoncol.2021.0586. JAMA Oncol. 2021. PMID: 34081097 Review.

2

POEMS Syndrome-Clinical Picture and Management. Current Knowledge.

Jurczyszyn A, Olszewska-Szopa M, Vesole D. Jurczyszyn A, et al. Clin Lymphoma Myeloma Leuk. 2023 Aug;23(8):575-582. doi: 10.1016/j.clml.2023.04.008. Epub 2023 Apr 26. Clin Lymphoma Myeloma Leuk. 2023. PMID: 37210272 Review.

3

Evidence-based medical treatment of POEMS syndrome.

Khwaja J, D'Sa S, Lunn MP, Sive J. Khwaja J, et al. Br J Haematol. 2023 Jan;200(2):128-136. doi: 10.1111/bjh.18400. Epub 2022 Aug 7. Br J Haematol. 2023. PMID: 35934319 Review.

4

POEMS Syndrome: Diagnosis and Investigative Work-up.

Dispenzieri A, Kourelis T, Buadi F. Dispenzieri A, et al. Hematol Oncol Clin North Am. 2018 Feb;32(1):119-139. doi: 10.1016/j.hoc.2017.09.010. Hematol Oncol Clin North Am. 2018. PMID: 29157614 Review.

5

Improvement of sexual function in POEMS syndrome after combination therapy of Lenalidomide and dexamethasone.

Yang H, Huang X, Cai Q, Wang C, Cao X, Zhou D, Li J. Yang H, et al. Orphanet J Rare Dis. 2016 Jun 18;11(1):80. doi: 10.1186/s13023-016-0461-8. Orphanet J Rare Dis. 2016. PMID: 27317315 Free PMC article.

6

Bortezomib plus dexamethasone as first-line therapy for patients with POEMS syndrome.

Gao XM, Yu YY, Zhao H, Cai H, Zhang L, Cao XX, Zhou DB, Li J. Gao XM, et al. Ann Hematol. 2021 Nov;100(11):2755-2761. doi: 10.1007/s00277-021-04609-6. Epub 2021 Jul 31. Ann Hematol. 2021. PMID: 34331562

7

Improvement of thyroid function in POEMS syndrome after combination therapy of lenalidomide and dexamethasone.

Yang H, Zhao H, Huang X, Cao X, Zhou D, Li J. Yang H, et al. Leuk Lymphoma. 2019 Feb;60(2):483-487. doi: 10.1080/10428194.2018.1485909. Epub 2018 Nov 8. Leuk Lymphoma. 2019. PMID: 30407096 Clinical Trial.

8

Single-agent daratumumab for refractory POEMS syndrome.

Tiew HW, Sampath VS, Gallardo CA, Christopher D, Chan SSW, Wong SW, Tso ACY, Lee LK, Fan BE. Tiew HW, et al. Am J Hematol. 2022 Jun 1;97(6):E189-E191. doi: 10.1002/ajh.26517. Epub 2022 Mar 11. Am J Hematol. 2022. PMID: 35253931 Free article. No abstract available.

9

Daratumumab monotherapy for relapsed POEMS syndrome.

Dima D, Valent J, Khouri J. Dima D, et al. Am J Hematol. 2023 Nov;98(11):E291-E294. doi: 10.1002/ajh.27050. Epub 2023 Aug 7. Am J Hematol. 2023. PMID: 37548551 No abstract available.

10

POEMS syndrome: origination from clonal plasma cells or B cells?

Zhou L, Lu J, Lin Z, Wang X, Luo L, Wang C, Hong L, Xu R, Huang H. Zhou L, et al. Hematology. 2023 Dec;28(1):2186044. doi: 10.1080/16078454.2023.2186044. Hematology. 2023. PMID: 36897012

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

98 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Results by year